Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep1095 | Thyroid cancer | ECE2016

Clinical usefulness of dynamic risk stratification in medullary thyroid cancer

Han Ji Min , Kwon Hyemi , Kim Won Gu , Jeon Min Ji , Kim Tae Yong , Kim Won Bae , Shong Young Kee

Purpose: To detect persistent/recurrent disease of medullary thyroid carcinoma (MTC) after initial surgery is important. The Tumor-Node-Metastasis (TNM) staging system is useful for predicting disease-specific mortality, but it is static and does not include postoperative serum calcitonin levels. We focused on the clinical usefulness of dynamic risk stratification (DRS) using the best response to initial therapy in patients with MTC.Methods: A total of 1...

ea0056gp251 | Thyroid non cancer | ECE2018

Thyroid-specific mitochondrial dysfunction results in abnormal thyrotropin responses

Joung Kyong Hye , Lee Jung Uee , Kim Ji Min , Lee Sang-Hee , Kim Seong-Min , Kim Hyun Jin , Shong Minho

Background: Optimal production of cellular energy and metabolites in mitochondria is one of the most important factors in endocrine organs that accomplish the momentary adaptation to ligand stimulation, such as insulin secretion and aldosterone biosynthesis. Although it has been suggested that thyroid gland function is also largely dependent on mitochondrial function, functional behavior of thyroid gland on compromised mitochondrial function remained to be identified. In this ...

ea0056p294 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Lobeglitazone, a novel thiazolidinedione, improves hepatic steatosis in diet-induced obese mice

choung Sorim , You Bo Ram , Kim Ji Min , Joung Kyong Hye , Kim Hyun Jin , Ku Bon Jeong

Although non-alcoholic fatty liver disease (NAFLD) patients are rapidly growing, there is not optimal therapy to improve NAFLD. NAFLD is strongly associated with insulin resistance. The peroxisome proliferator-activated receptor (PPAR) activator thiazolidinediones (TZD) is an insulin sensitizer, and have been focused as the drug for NAFLD. However, the TZD remain debate as drug of choice on NAFLD because of its conflicting results on the hepatic steatosis and fibrosis. Lobegli...

ea0049ep1366 | Thyroid (non-cancer) | ECE2017

Dynamic risk stratification for predicting recurrence in patients with differentiated thyroid cancer treated without radioactive iodine remnant ablation therapy

Park Suyeon , Kim Won Gu , Song Eyun , Oh Hye-Seon , Kim Mijin , Kwon Hyemi , Jeon Min Ji , Kim Tae Yong , Shong Young Kee , Kim Won Bae

Background: Increased incidence of small differentiated thyroid cancer (DTC) has emphasized the need for risk stratification and individualized disease management for these low risk DTCs. The aim was to validate a new dynamic risk stratification (DRS) system for prediction of structural recurrent/persistent disease in patients with DTC treated without radioactive iodine (RAI) remnant ablation therapy.Methods: This historical cohort study included 357 pat...